HALO logo
halo search icon
APLI
Appili Therapeutics Inc Class A

APLI · Appili Therapeutics Inc Class A

0.01

CAD
0.00 (0.00%)
23/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

CA$1.32M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

N/A

MQV Rating

5Very Weak

As at 23/07/2026 12:00:00 AM

Price Chart

Description

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.

  • All-Companies
  • HALO All
  • Near 52 Week Low
  • Near Support

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

Low 0.01 - 0.04

Trade Value (12mth)

US$480.00

1 week

-33.33%

1 month

-50%

YTD

-50%

1 year

-66.67%

All time high

1.89

Additional Data

Shares Outstanding (Fully Diluted)

124m

HALO Sector

Healthcare

Next Company Report Date

30-Jun-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CAD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
The current share price of Appili Therapeutics Inc Class A (APLI:TSE) is CAD$0.01.
2
What is the 52-week high share price for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
The 52-week high share price for Appili Therapeutics Inc Class A (APLI:TSE) is CAD$0.04.
3
What is the 52-week low share price for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
The 52-week low share price for Appili Therapeutics Inc Class A (APLI:TSE) is CAD$0.01.
4
What is the dividend yield for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) does not pay a dividend.
5
What was Appili Therapeutics Inc Class A (APLI:TSE) last dividend payment?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) does not pay a dividend.
6
What is the franking level for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) has a franking level of 0.00%.
7
In which sector is Appili Therapeutics Inc Class A (APLI:TSE) classified?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) is classified in the Healthcare.